12 Health Care Stocks Moving In Wednesday's Intraday Session

Gainers

  • VYNE Therapeutics VYNE stock moved upwards by 38.0% to $4.32 during Wednesday's regular session. VYNE Therapeutics's stock is trading at a volume of 36.2 million shares as of 13:30 EST. This is 174722.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $14.1 million.
  • Biolase BIOL shares increased by 36.88% to $0.36. As of 13:30 EST, Biolase's stock is trading at a volume of 21.4 million, which is 4206.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $9.4 million.
  • Matinas BioPharma Hldgs MTNB shares rose 26.67% to $0.64. As of 13:30 EST, this security is trading at a volume of 2.1 million shares, making up 774.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $138.9 million.
  • Vallon Pharmaceuticals VLON shares rose 20.02% to $0.51. Vallon Pharmaceuticals's stock is trading at a volume of 2.2 million shares as of 13:30 EST. This is 33.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $6.8 million.
  • Legend Biotech LEGN stock moved upwards by 18.83% to $62.08. Legend Biotech's stock is trading at a volume of 6.4 million shares as of 13:30 EST. This is 1057.8% of its average full-day volume over the last 100 days. The company's market cap stands at $10.2 billion.
  • iBio IBIO shares rose 16.66% to $1.26. The current volume of 539.3K shares is 16.3% of iBio's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $15.5 million.

Losers

  • Allarity Therapeutics ALLR shares decreased by 42.2% to $0.67 during Wednesday's regular session. The current volume of 13.9 million shares is 788.1% of Allarity Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST).
  • Femasys FEMY stock fell 19.05% to $1.02. The current volume of 263.6K shares is 738.6% of Femasys's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $12.1 million.
  • Celyad Oncology CYAD stock decreased by 19.01% to $0.65. The market value of their outstanding shares is at $14.6 million.
  • Citius Pharma CTXR stock decreased by 17.88% to $1.35. Trading volume for this security as of 13:30 EST is 3.1 million, which is 339.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $198.1 million.
  • HTG Molecular Diagnostics HTGM stock declined by 14.95% to $3.13. HTG Molecular Diagnostics's stock is trading at a volume of 244.1K shares as of 13:30 EST. This is 77.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $3.2 million.
  • Bellicum Pharmaceuticals BLCM stock decreased by 14.75% to $0.44. Bellicum Pharmaceuticals's stock is trading at a volume of 2.1 million shares as of 13:30 EST. This is 223.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $3.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: MoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!